A new steroidal saponin with antiinflammatory and antiulcerogenic properties from the bulbs of Allium ampeloprasum var. porrum  by Adão, Camila Rodrigues et al.
Fitoterapia 82 (2011) 1175–1180
Contents lists available at SciVerse ScienceDirect
Fitoterapia
j ourna l homepage: www.e lsev ie r.com/ locate / f i to teA new steroidal saponin with antiinﬂammatory and antiulcerogenic
properties from the bulbs of Allium ampeloprasum var. porrum
Camila Rodrigues Adão, Bernadete Pereira da Silva, José Paz Parente⁎
Laboratório de Química de Plantas Medicinais, Núcleo de Pesquisas de Produtos Naturais, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro,
P.O. Box 68045, CEP 21941-971 Rio de Janeiro, Brazila r t i c l e i n f o⁎ Corresponding author. Tel.: +55 21 2562 6791; fa
E-mail address: parente@pq.cnpq.br (J.P. Parente).
0367-326X © 2011 Elsevier B.V.
doi:10.1016/j.ﬁtote.2011.08.003
Open access under the Ea b s t r a c tArticle history:
Received 21 February 2011
Accepted in revised form 25 July 2011
Available online 11 August 2011A new steroidal saponinwas isolated from the bulbs of Allium ampeloprasum var. porrum L. On the
basis of chemical evidence, comprehensive spectroscopic analyses and comparison of known
compounds, its structure was established as (3β,5α,6β,25R)-6-[(β-D-glucopyranosyl)oxy]-
spirostan-3-yl O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-(1→3)]-β-D-galactopyra-
noside (1). Results of the present study indicated that the steroidal saponin showed haemolytic
effects in the in vitro assays and demonstrated antiinﬂammatory activity and gastroprotective
property using in vivomodels.
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Allium ampeloprasum var. porrum L. (Liliaceae), a bulbous
perennial plant, is one of the daily edible green vegetables for
Brazilian people. It is widely cultivated and used as food in
Brazil. This plant is used, not only as food, but also as
medicine. The bulbs have been reputedly used in the
traditional Brazilian medicine for treating inﬂammatory
symptoms. The crushed bulb is used to treat initial stages of
cough, mucous secretion and sore throat. The fresh juice is
taken orally as a stomachic and antispasmodic and is also
reputed to possess digestive properties [1]. While chemical
studies on saponins of Allium specimens have been reported
[2–4], no chemical investigation of A. ampeloprasum var.
porrum has been reported as yet. In this paper, we report the
structural elucidation and biological activities of the new
steroidal saponin 1 (Fig. 1).x: +55 21 2270 2683.
lsevier OA license. 2. Experimental
2.1. General
Melting points were determined by an Electrothermal 9200
micro-meltingpoint apparatus and are uncorrected. Theoptical
rotations were measured with a Perkin Elmer 243B polarim-
eter. IR spectra were measured with a Perkin Elmer 599B
spectrometer. The MALDI-TOFMS was obtained using a
Perseptive Voyager RP mass spectrometer. GC-EIMS was
carried out with FID using a ZB glass capillary column
(0.25×50 m). Mass spectra were taken with a VG Auto SpecQ
spectrometer. NMR experiments were performed with a
Mercury-300 spectrometer at 308.1 K. All the 2D NMR spectra
were acquired in pyridine-d5 with tetramethylsilane (δ=0.00)
used as internal standard. 1H NMR spectra were recorded at
300 MHz and 13C NMR spectra at 75 MHz. Silica gel columns
(230–400 mesh ASTM, Merck) and Sephadex LH-20 (Pharma-
cia) were used for column chromatography (CC). Thin layer
chromatography (TLC) was performed on silica gel plates
(Kieselgel 60F254, Merck) using the following solvent systems:
(A) CHCl3/MeOH/H2O (65:35:10, v/v/v, lower phase) for
steroidal saponin 1, (B) CHCl3/MeOH (95:5, v/v) for sapogenin
1a, and (C) n-BuOH/Me2CO/H2O (4:5:1, v/v/v) for
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Fig. 1. Structure of compound 1.
Table 1
13C NMR (75 MHz) data of compound 1 in pyridine-d5.
Carbon no. δC DEPT Carbon no. δC DEPT
Agl 1 38.28 CH2 Gal 1 101.77 CH
2 28.70 CH2 2 80.20 CH
3 77.90 CH 3 86.92 CH
4 31.25 CH2 4 69.80 CH
5 47.39 CH 5 77.01 CH
6 79.25 CH 6 61.96 CH2
7 40.27 CH2 Glc 1 104.29 CH
8 30.07 CH 2 75.03 CH
9 54.08 CH 3 77.90 CH
10 35.59 C 4 72.55 CH
11 20.70 CH2 5 77.51 CH
12 39.67 CH2 6 60.19 CH2
13 40.34 C Glc 1 104.83 CH
14 55.83 CH 2 74.21 CH
15 32.20 CH2 3 77.78 CH
16 80.61 CH 4 71.01 CH
17 62.52 CH 5 77.51 CH
18 16.09 CH3 6 61.56 CH2
19 15.48 CH3 Glc 1 103.39 CH
20 41.48 CH 2 74.58 CH
21 14.52 CH3 3 77.78 CH
22 108.72 C 4 70.11 CH
23 31.71 CH2 5 77.51 CH
24 29.45 CH2 6 62.34 CH2
25 30.07 CH
26 66.69 CH2
27 16.80 CH3
The assignments were made on the basis of HMBC, HSQC and HMQC
experiments.
13C multiplicities were determined by DEPT experiments. The following
convention is used: Agl = aglycone, Gal = β-D-galactopyranosyl, Glc = β-D-
glucopyranosyl.
1176 C.R. Adão et al. / Fitoterapia 82 (2011) 1175–1180monosaccharides. Spray reagents were orcinol/H2SO4 for
steroidal saponin 1 and monosaccharides and CeSO4 for
sapogenin 1a.
2.2. Plant material
The bulbs of A. ampeloprasum var. porrumwere purchased
from a nursery in Rio de Janeiro, Brazil, in September 2007.
The bulbs were cultivated, and a voucher specimen (LQPM
60) of the plant was deposited at the Laboratory of Medicinal
Plant Chemistry, Federal University of Rio de Janeiro.
2.3. Extraction and isolation
The fresh bulbs (1.16 kg) were cut into small pieces and
extracted with MeOH (5 l) for 72 h at room temperature. The
extract was concentrated under reduced pressure to remove
most of the MeOH and the resulting aqueous phase (500 ml)
was extracted at room temperaturewith n-BuOH (500 ml). This
procedure was repeated and the resulting organic phase was
evaporated in vacuo to give a crude material (3.57 g). It was
dissolved in MeOH (50 ml) and roughly chromatographed
(714 mg/10 ml each time) on Sephadex LH-20 (3.8×65 cm)
eluted with MeOH (1 l; fraction of 25 ml) afforded a crude
saponin (fractions 19–23; 5×186 mg). The fractions were
combined based on the TLC proﬁles using the solvent system
(A) CHCl3/MeOH/H2O (65:35:10, v/v/v, lower phase). The crude
saponin (930 mg)was subjected to column chromatography on
silica gel (2.8×90 cm) eluted with CHCl3/MeOH/n-BuOH/H2O
(10:5:1:4, v/v/v/v; 2 l; fraction of 25 ml) to afford a TLC
homogeneous compound 1 (fractions 59–62; 250 mg;
Rf=0.41) which gave a dark blue color with orcinol/H2SO4.
2.4. Spectrometric identiﬁcation of compound 1
(3β,5α,6β,25R)-6-[(β-D-Glucopyranosyl)oxy]-spirostan-3-
yl O-β-D-glucopyranosyl-(1→2)-O-[β-D-glucopyranosyl-
(1→3)]-β-D-galactopyranoside (1): amorphous powder, mp
273–275 °C; [α]D25– 58° (c 0.1, CHCl3-MeOH (1:1)). IR νmax
(KBr): 3380 (OH), 2935 (CH), 1445, 1375, 1235, 1150, 1050, 915,
898, 860, 745 cm−1. 1H NMR (pyridine-d5): δ 3.93 (1 H,m, H-3),
0.95 (1H,m, H-5), 3.88 (1H,m, H-6), 4.45 (1H,m, H-16), 0.86 (3
H, s, H-18), 1.20 (3 H, s, H-19), 1.84 (1 H,m, H-20), 1.17 (3 H, d,
J=6.7 Hz, H-21), 1.46 (1 H, m, H-25), 3.38 (1 H, dd, J=10.7,10.7 Hz, H-26ax), 3.46 (1H, dd, J=2.8, 10.7 Hz, H-26 eq), 0.68 (3
H, d, J=5.6 Hz, H-27), 4.92 (1H, d, J=7.3 Hz, Gal H-1), 5.12 (1H,
d, J=8.1 Hz,Glc H-1), 5.16 (1H,d, J=7.6 Hz,Glc H-1), 5.20 (1H,
d, J=7.6 Hz, Glc H-1). 13C NMR (pyridine-d5) data: see Table 1.
MALDI-TOFMS:m/z 1104.2065 [M+Na]+ (calcd. 1104.2135).
2.5. Acid hydrolysis of compound 1
A solution of compound 1 (100 mg) in 1 MHCl/1,4-dioxane
(1:1, v/v; 10 ml) was heated in a sealed tube for 1 h at 100 °C.
After cooling, the reaction mixture was neutralized with 1 M
NaOH in MeOH and evaporated to dryness. The salts that
1177C.R. Adão et al. / Fitoterapia 82 (2011) 1175–1180deposited on addition ofMeOHwereﬁltered off, and theﬁltrate
was passed through a Sephadex LH-20 column (1.6×50 cm)
eluted withMeOH (200 ml; fraction of 10 ml) to afford twenty
fractions. The hydrolysates (fractions 10–13) were combined
on the basis of TLC behaviors, concentrated under vacuum and
the dried residue was chromatographed on silica gel column
(1.6×40 cm) with gradient CHCl3/MeOH (19:1 to 7:3; 1 l;
fraction of 10 ml) to afford the sapogenin 1a (30 mg) and sugar
mixture (48 mg). The sapogenin 1a (Rf=0.40) and the sugar
mixturewereobtained from the fractions analyzedby silica gel-
TLC using the solvent systems (B) CHCl3/MeOH (95:5, v/v) and
(C) n-BuOH/Me2CO/H2O (4:5:1, v/v/v), respectively. A sample
of the sugar mixture (1 mg) was dissolved in pyridine (100 μl)
and analyzed by silica gel-TLC in the above described solvent
(C). After spraying with orcinol/H2SO4, glucose and galactose
gave blue spots at Rf values of 0.38 and 0.35, respectively.
(3β,5α,6β,25R)-Spirostan-3,6-diol (1a): Colorless needles
from benzene, mp 239–240 °C; [α]D25 – 72.5° (c 0.5, CHCl3); IR
νmax (KBr): 3520, 3250 (OH), 2955, 2930, 2875, 2850 (CH),
1450, 1375, 1340, 1240, 1175, 1075, 1055, 1015, 1005, 980,
955, 915, 900, 860 cm−1 (intensity 915b900, 25R-spiroke-
tal); EIMS: m/z 432 [M]+, 139 [C9H15O]+; The 1H and 13C
NMR (pyridine-d5) data agreed well with those of literature
data [5].
2.6. Molar carbohydrate composition of compound 1
Dried compound1 (1 mg) was dissolved in 0.5 ml of
methanolic 0.5 M HCl. Nitrogen was bubbled through the
solution for 30 s and then the ampoule was sealed. After
methanolysis for 24 h at 80 °C, the solution was concentrated
under reduced pressure at 45 °C. The residue was dried for
12 h in a vacuum desiccator over P2O5. The dried sample was
trimethylsilylated with 0.1 ml of silylating agent pyridine/
hexamethyldisilazane/trimethylchlorosilane (5:1:1, v/v/v) for
30 min at room temperature. The molar carbohydrate compo-
sition of the glycosidicmoiety of 1was determined by GC-EIMS
analyses of its monosaccharides as their trimethylsilylated
methylglycosides [6].
2.7. Determination of D, L conﬁgurations of monosaccharides of
compound 1
A sample of the sugar mixture (0.5 mg), obtained after acid
hydrolysis of 1 (see Section 2.5.), was dissolved in (−)-2-
butanol containing 1 M HCl (0.5 ml). The solution was ﬂushed
with nitrogen and heated for 6 h at 60 °C. The reaction solution
was treated with an excess amount of Ag2CO3 and the mixture
was centrifuged. The supernatant was evaporated to dryness at
45 °C, and the residuewas dried in a desiccator containing P2O5
[7]. The resultant syrupwas trimethylsilylated according to the
procedure of Kamerling et al. [6]. The conﬁgurations of
monosaccharides of theglycosidicmoietyof1weredetermined
by capillary GC and GC-EIMS of their trimethylsilylated (−)-2-
butyl glycosides [7].
2.8. Methylation analysis of compound 1
Compound 1 (1 mg) was dissolved in dimethylsulfoxide
(200 μl) in a Teﬂon-lined screw-cap tube. Lithium methyl-
sulﬁnyl carbanion (200 μl), prepared according to theprocedure of Parente et al. [8], was added to the solution
under an inert atmosphere and the mixture was sonicated for
60 min. After cooling to −4 °C, cold methyl iodide (400 μl)
was added. Sonication was conducted in a sonication bath
(20 °C) for 45 min. The methylation was terminated by the
addition of water (4 ml) containing sodium thiosulfate, and
the permethylated product extracted with chloroform
(3×2 ml) and evaporated [8]. The methyl ethers were
obtained after hydrolysis (4 N TFA, 2 h, 100 °C) and analyzed
as alditol acetates by GC-EIMS [9].2.9. Haemolytic activity
Normal human red blood cell suspension (0.5 ml of 0.5%)
was mixed with 0.5 ml diluent containing 5, 10, 20, 30, 40, 50,
100, 250 and 500 μg/ml of compound 1 or the commercial
saponin isolated from Quillaja saponaria (QS-21) in saline
solution. Mixtures were incubated for 30 min at 37 °C and
centrifuged at 70×g for 10 min. Free haemoglobin in the
supernatant was measured by absorbance at 412 nm. Saline
and distilled water were included as minimal and maximal
haemolytic controls. The haemolytic percents developed by the
saline control were subtracted from all groups. The adjuvant
concentration inducing 50% of the maximum haemolysis was
considered the HD50 (graphical interpolation). Experiments
included triplicate at each concentration [10].2.10. Animals
Male Swiss mice (three months old, 25–35 g) were
obtained from the central animal care facilities, Health
Sciences Centre, Federal University of Rio de Janeiro, Brazil.
The mice were maintained under standard laboratory
conditions (12 h light/dark cycle, at 22±2 °C). Standard
pellet food and water were available ad libitum. The
experimental protocol was performed according to the
“Principles of Laboratory Animal Care” (NIH Publication
85-23, revised 1985).2.11. Antiinﬂammatory activity
Antiinﬂammatory activity was evaluated by the carra-
geenan-induced oedema method [11]. Male Swiss mice
(three months old, 25–35 g) in groups of ﬁve were admin-
istered orally with 1 ml of saline solution as the negative
control or compound 1 (100 mg/kg) or the reference
compound dexamethasone (25 mg/kg) dissolved in saline
solution as positive controls. Acute inﬂammation was
produced by subplantar injection of 50 μl of 1% freshly
prepared colloidal suspension of carrageenan in physiological
saline injected into the subplantar region of the right hind
paw of the mice, 1 h after the oral administration of test
sample as well as the negative and positive controls. The
footpad thickness were measured with a spring-loaded dial
gauge (Mitutoyo Corp., Tokyo, Japan) before and every 1 h
during 5 h after induction of inﬂammation. Percent inhibition
of the inﬂammation was determined by applying statistical
methods followed by the calculation of percent inhibition for
each group by comparing with control group.
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Antiulcerogenic activity was evaluated by measuring
acute gastric lesions induced by acidiﬁed ethanol [12]. Male
Swissmice (threemonths old, 25–35 g) in groups of ﬁvewere
fasted for 24 h before the experiment and administered orally
with 1 ml of pure water as the negative control, or compound
1 (100 mg/kg), or the reference compound cimetidine
(100 mg/kg) dissolved in vehicle as positive control. One
hour after the treatments, all animals received orally 200 μl of
acidiﬁed ethanol solution (0.3 M HCl/EtOH) to induce gastric
lesions. The animals were killed 1 h after treatment with the
ulcerogenic agent and the stomachs removed, opened along
the greater curvature and rinsed with physiological saline to
determine the lesion damage. The degree of gastric mucosal
damage was evaluated from digital pictures using a comput-
erized image analysis system. The percentage of the total
lesion area (haemorrhagic lesions) to the total surface area of
the stomach was deﬁned as the ulcer index [13].
3. Results and discussion
Compound 1was obtained as amorphous solid and gave a
positive Liebermann–Burchard test for a steroidal saponin. It
revealed a quasi-molecular weight ion peak atm/z 1104.2065
[M+Na]+ in the MALDI-TOFMS. In the 13C NMR spectrum, of
the ﬁfty-one carbon signals observed, there are four methyl
groups, fourteen methylene groups (ﬁve of which were
oxygenated), thirty methine groups (twenty-three of which
were oxygenated) and three quaternary carbon atoms (one of
which was oxygenated). The number of hydrogens attached
to each individual carbon atom was determined by the DEPT
spectrum. On the basis of the above mentioned MS and NMR
spectral data (Table 1), compound 1 was assumed to be a
saponin with the molecular formula C51H84O24, bearing four
monosaccharide moieties.
In addition to this, the spirostanol glycosidic nature of
compound 1 was indicated by the strong absorption bands at
3380 cm−1 for the hydroxyl group and the characteristic 25
(R)-spiroketal absorption bands 898 and 915 cm−1 (intensity,
915b898 cm−1) in the IR spectrum [5,14]. The 25R stereo-
chemistry of the Me-27 group was conﬁrmed by protons and
carbons resonances at positions 25, 26 and 27 in comparison
with data reported in the literature [15,16]. The A/B trans-ring
fusionwas deduced from the signals at δ 47.39 (CH, C-5), 54.08
(CH, C-9) and 15.48 (CH3, C-19) indicating that the aglycone of
1 is a 5β steroidal sapogenin [5,15], conﬁrmed by one proton at
δ 0.95 (m, H-5). On inspection of the 1H and 13C NMR spectral
data of compound 1, the structure of the aglycone moiety was
identical with (3β,5α,6β,25R)-spirostan-3,6-diyl. The 1H NMR
spectrum of 1 displayed signals for four anomeric protons at δ
4.92 (d, J=7.3 Hz), 5.12 (d, J=8.1), 5.16 (d, J=7.6) and 5.20 (d,
J=7.6),whichgave correlations in theHSQCspectrumwith 13C
NMR signals at δ 101.77, 103.39, 104.83 and 104.29, respec-
tively. Evaluation of chemical shifts and spin–spin couplings
allowed the identiﬁcation of one β-galactopyranosyl unit (Gal)
and three β-glucopyranosyl units (Glc, Glc and Glc ). The
attachments of the sugarmoieties to the aglyconemoietywere
established by 1H-1H-COSY, HMBC and HMQC experiments.
The HMBC and HMQC spectra displayed long range couplings
between a galactose-H-1 at δ 4.92 and aglycone-C-3 at δ 77.90,and between a terminal glucose-H-1” at δ 5.12 and aglycone-
C-6 at δ 79.25. In addition to this, long range couplings were
observed between a terminal glucose-H-1 at δ 5.20 and
galactose-C-2 at δ 80.20, and between a terminal glucose-H-1
at δ5.16 andgalactose-C-3 at δ86.92, indicating that compound
1 is undoubtedly a bisdesmosidic steroidal saponin.
The sequence of the sugar chain was conﬁrmed by
methylation analysis [8] which furnished 1,5-di-O-acetyl-
2,3,4,6-tetra-O-methyl glucitol and 1,2,3,5-tetra-O-acetyl-
4,6-di-O-methyl galactitol in the molar ratio of 3:1. These
results indicated that the sugar-aglycone linkage and the
sugar chain sequence of compound 1 was as shown in Fig. 1.
On acid hydrolysis, compound 1 gave a sapogenin, glucose
and galactose. The sapogenin was identiﬁed as
(3β,5α,6β,25R)-spirostan-3,6-diol (β-chlorogenin) (1a) by
comparison of mp, [α]D, IR, 1H and 13C NMR and EIMS data
with those of literature data [5]. The molar carbohydrate
composition of 1 indicated the presence of four neutral
monosaccharides: glucose-galactose (3:1). Their absolute
conﬁgurations were determined by GC of their trimethylsi-
lylated (−)-2-butylglycosides [7]. D-Glucose and D-galactose
were detected.
Consequently, on the basis of MALDI-TOFMS, IR, 1H and 13C
NMR spectroscopy and chemical reactions, the structure of
compound 1was established as (3β,5α,6β,25R)-6-[(β-D-gluco-
pyranosyl)oxy]-spirostan-3-yl O-β-D-glucopyranosyl-(1→2)-O-
[β-D-glucopyranosyl-(1→3)]-β-D-galactopyranoside.
According to the literature, steroidal saponins are shown
to possess several physiological properties depending on
their chemical structures, such as haemolytic activity and
capacity for alteration of membrane permeability. Addition-
ally, these compounds isolated from medicinal plants have
been reported to have important biological activities, such as
stimulation of lymphocyte proliferation [17], promotion of
antibody production [18], radical scavenging capacity [19],
and inhibition of the production of inﬂammatory cytokines by
activated macrophages [20]. In order to conﬁrm the utiliza-
tion of this species in the traditional medicine and to evaluate
the biological properties of compound 1 (Fig. 1), the
antiinﬂammatory activity and gastroprotective property
were investigated using in vivo models. Additionally, it was
screened for haemolytic activity in the in vitro assays.
Generally, steroidal saponins possess powerful haemolytic
capacity because steroids have higher afﬁnities for cholesterol
on erythrocyte membranes [21]. The ability of compound 1 to
induce haemolysis of human red blood cells was investigated
and compared with the saponin QS-21 isolated from Q.
saponaria, a substance commonly used in animal and human
experimental models. According to the results obtained,
compound 1was shown to possess potent haemolytic capacity
(HD50 6.5 μg/ml), which is of the same order of magnitude as
the reference commercial compound (HD50 5 μg/ml). This can
be explained by the amphipathic characteristic of its structure,
containing a hydrophobic steroidal nucleus and two hydro-
philic carbohydrate moieties.
In addition to this, the antiinﬂammatory activity of
compound 1 was investigated using an acute inﬂammation
model. The results were measured by inhibition of carra-
geenan-induced mouse paw oedema [11]. The carrageenan-
induced inﬂammation is a biphasic phenomenon. The early
phase of oedema is attributed to the release of histamine,
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Fig. 2. Antiinﬂammatory activity of compound 1 and the reference compound
dexamethasone against mouse paw oedema induced by carrageenan. Results
are mean±S.E.M. (n=5); *pb0.05, **pb0.01, signiﬁcantly different from the
control group.
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mainly from the potentiating effects of prostaglandins on
mediator release [22]. Compound 1 showed signiﬁcant
antiinﬂammatory potential, promptly controlling both phases
of inﬂammation and provoking an inhibition of oedema
formation similar to the reference compound dexamethasone
(Fig. 2). In comparison with the literature reports, compound
1 showed antiedematous properties with potency similar to
that of bioactive compounds isolated from other medicinal
plants used against inﬂammatory disorders [20,23].
Generally, commercially available antiinﬂammatory drugs
are associatedwith unwanted side effects especially ulceration,
which is the most common and serious problem [24]. Since
there are popular information about the use of this plant for the
treatment of digestive disorders, with the aim to conﬁrm its
utilization in the traditional medicine, the gastroprotective
property of compound 1was investigated. The antiulcerogenic
activity was evaluated by measuring the inhibition of acute
gastric lesions induced by acidiﬁed ethanol [12].
Acidiﬁed ethanol tends to dissolve the components of the
mucous membrane of the stomach, bringing gastric blood
ﬂow to a standstill that contributes to the development of the
haemorrhage and necrotic aspects of tissue injury [25]. By
macroscopic observations, in the control animals that0 10 20 30 40 50 60 70 80 90 100 110
control
cimetidine
compound 1
Area of gastric lesion (percentage of total area)
*
**
Fig. 3. Antiulcerogenic activity of compound 1 and the reference compound
cimetidine against acidiﬁed ethanol induced gastric lesions (0.3 M HCl/EtOH).
Results are mean±S.E.M. (n=5); *pb0.05, **pb0.01, signiﬁcantly different
from the control group.received only water before acidiﬁed ethanol administration,
intense and widespread gastric hyperemia and thickened
lesions were evident. In contrast, the stomachs of the animals
which received compound 1 showed an aspect close to
normality, with signiﬁcant reduction in gastric hyperemia
and in number and severity of lesions. This protective action
is closely related to the reference compound cimetidine at the
same dosage [24]. The intensity of gastric ulcers was
quantiﬁed by the percentage of the injury area in relation to
the control group (Fig. 3).
This result suggests that compound 1 probably interfere
with the ulcerogenic mechanism, showing a cytoprotective
property. The mechanisms which protect the gastric mucosa
against acute attack by necrotic agents involve a variety of
events [26]. Among these, a crucial role is played by mucus
production, which is an important protective factor for the
gastric mucosa and consists of a viscous, elastic and adherent
barrier formed by water and glycoproteins that covers the
entire gastrointestinal mucosa. The protective properties of
themucus barrier depend not only on its structure but also on
the amount or thickness of the layer covering the mucosal
surface [27]. Since literature reports indicated that steroidal
saponins possess the ability to increase themucosal defensive
factors, inducing the turnover of glycoproteins in the mucosal
cells, thus increasing the quantity of cellular mucus, probably
this can be the mode of action of compound 1, preventing the
penetration of the necrotizing agent or interacting with the
macromolecules of the gastric mucosa [28,29].
In conclusion, the investigation of the biological properties
of compound 1 indicated that this substance may be the
potential therapeutic agent involved in the gastroprotective
property and the treatment of inﬂammatory conditions,
justifying the use of this plant as a food source and in the
traditional medicine.
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